Basic Information
ID DDInter1869
Drug Type small molecule
Molecular Formula C24H44O6
Molecular Weight 428.610
CAS Number 620-67-7
Description Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation.[L14612] In clinical trials, patients with long chain fatty acid oxidation disorders (lc-FAODs) treated with triheptanoin are less likely to develop hypoglycemia, cardiomyopathy, rhabdomyolysis, and hepatomegaly.[A214812,A214817] Complications in lc-FAOD patients are reduced from approximately 60% to approximately 10% with the addition of triheptanoin.[A214817] Triheptanoin was granted FDA approval on 30 June 2020.[L14612]
ATC Classification A16AX17
IUPAC Name 1,3-bis(heptanoyloxy)propan-2-yl heptanoate
InChI PJHKBYALYHRYSK-UHFFFAOYSA-N
Canonical SMILES CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
Useful Links DrugBank PubChem Substance ChemSpider Wikipedia ChEMBL ZINC
Interactions with Triheptanoin
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note